RAPT THERAPEUTICS, INC.
561 Eccles Avenue
South San Francisco, California 94080
August 1, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attention: | Ms. Sonia Bednarowski |
Mr. Dietrich King
Ms. Sasha Parikh
Mr. Jim Rosenberg
| Re: | RAPT Therapeutics, Inc. |
| Registration Statement on Form S-1, as amended (File No. 333-232572) |
Ladies and Gentlemen:
Further to the telephone conversation yesterday between Michael Tenta and Ms. Bednarouski, on behalf of RAPT Therapeutics, Inc. the undersigned hereby confirms the withdrawal of the request for acceleration dated July 26, 2019 with respect to the above-referenced Registration Statement on Form S-1, as amended (File No. 333-232572).
| Very truly yours, | ||
| RAPT THERAPEUTICS, INC. | ||
| By: | /s/ Eric Hall | |
| Name: | Eric Hall | |
| Title: | Interim Chief Financial Officer and Secretary | |
cc Michael Tenta